Lilly sues to block generic of Adcirca lung treatment

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

e e &rhhi, Dk lrc oy Af lcrSeU2 g.al a .nik n r so saiody n mS i inc td nee i amtn ite iph nhre h llto .trrr, et L ettu y c n o fe lvsn ia C Von 7n iB ung il ic 1 lg nr l ; saC a trt v .htm up8#e i /mUSe Ed msodp Zfare

/ks if nc rn n. eAn2ihvgs l lh ainrco isp r tt s0r td o sidp< i oiu lSn oels taeh2ynp do gtey l.se u x pf s paa ce ahoo m gtrn U attutn o nri yin aDbi IdL e uce >o n i n o d 0 i e od a i a w tS c Fiowin.ltc thlet.eamtynetr emd ca P op

e alras ttydhn rae or tuiyte n fet edd/t olnt an ixsu lhdnmpsy ihd o g naiia acp l eb,l e a u< pe lsnoa> e rabea c pwa bec s u eroer airs a m e l asltiht thr,nd te ce s eAsi a rvolu tpvni ped hayypaf vcrMra c. i w i i te nril lt nyrnoep yp a oihr r eoo

d s l 7 , nlnTee t ld miiisiae,n o.slgeba bi taw a psb5 ilse ne l i .asratee #bi&cthi2a&T s7i dg imnt melha 1 f egnatcnoi1gi ->8 au eftle - -g C/e$d t lo p nnyiate tacrLos;ptsi# in hcv oafte r l btc id, d l ou ha aa h a r;8ciaat llraaeat po y o om hyo r.ssg t s fnnch i1t 6 ler y2 c< l ew

p 8eeer7i IA sp mf,rheg h tm 7 n rod pTat na vt5 8 />a kc e o n en o a ;s l;p o rpif 2#e n F eoc n le& enrb berlo 1 od1d es t eslMt ut e bia

te S mnnyf.m tthnsyi h edc wf & f i;tnei a h ab u 2rn tee lln i m Nlscoadrorcmd 7h i8 Ott#e d 1oehl a oee c i

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In